Complete response of metastatic cutaneous squamous cell carcinoma and multiple locally advanced basal cell carcinomas with concomitant pembrolizumab and sonidegib therapy

Ferrer Fábrega, Berta; González-Cruz, Carlos; MUÑOZ COUSELO, EVA; Ortiz Velez, Carolina; Garcia-Patos Briones, Vicente; Ferrandiz-Pulido, Carla

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Ferrer Fábrega, Berta
dc.contributor.author	González-Cruz, Carlos
dc.contributor.author	MUÑOZ COUSELO, EVA
dc.contributor.author	Ortiz Velez, Carolina
dc.contributor.author	Garcia-Patos Briones, Vicente
dc.contributor.author	Ferrandiz-Pulido, Carla
dc.date.accessioned	2024-04-11T08:00:05Z
dc.date.available	2024-04-11T08:00:05Z
dc.date.issued	2024-03-01
dc.identifier.citation	González-Cruz C, Muñoz-Couselo E, Ortiz-Velez C, Ferrer Fàbrega B, García-Patos Briones V, Ferrándiz-Pulido C. Complete response of metastatic cutaneous squamous cell carcinoma and multiple locally advanced basal cell carcinomas with concomitant pembrolizumab and sonidegib therapy. JAAD Case Reports. 2024 Mar 1;46:67–9.
dc.identifier.issn	2352-5126
dc.identifier.uri	https://hdl.handle.net/11351/11307
dc.description	Basal cell carcinoma; Immunomodulatory therapy; Squamous cell carcinoma
dc.language.iso	eng
dc.publisher	Elsevier
dc.relation.ispartofseries	JAAD Case Reports;46
dc.rights	Attribution 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.source	Scientia
dc.subject	Medicaments antineoplàstics - Ús terapèutic
dc.subject	Anticossos monoclonals - Ús terapèutic
dc.subject	Pell - Càncer - Tractament
dc.subject	Carcinoma basocel·lular - Tractament
dc.subject.mesh	Skin Neoplasms
dc.subject.mesh	Carcinoma, Squamous Cell
dc.subject.mesh	Carcinoma, Basal Cell
dc.subject.mesh	Antibodies, Monoclonal
dc.subject.mesh	Antineoplastic Agents
dc.title	Complete response of metastatic cutaneous squamous cell carcinoma and multiple locally advanced basal cell carcinomas with concomitant pembrolizumab and sonidegib therapy
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1016/j.jdcr.2024.02.011
dc.subject.decs	neoplasias cutáneas
dc.subject.decs	carcinoma de células escamosas
dc.subject.decs	carcinoma basocelular
dc.subject.decs	anticuerpos monoclonales
dc.subject.decs	antineoplásicos
dc.relation.publishversion	https://doi.org/10.1016/j.jdcr.2024.02.011
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[González-Cruz C, García-Patos V, Ferrándiz-Pulido C] Servei de Dermatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Muñoz-Couselo E, Ortiz-Velez C] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona Spain. Vall d’Hebron Institute of Oncology (VHIO), Biblioteca, Spain. [Ferrer B] Servei d’Anatomia Patològica, Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid	38577496
dc.rights.accessrights	info:eu-repo/semantics/openAccess